MiniMed Group, Inc. 10-Q

Item 3. Quantitative and Qualitative Disclosures About Market Risk Currency Exchange Rate Risk Our operations are primarily located in the U.S., but we operate in approximately 80 countries globally. A significant portion of our sales are from EMEA, where fluctuations in the rate of exchange between the U.S. dollar and the local currency could adversely affect our financial results, including income and losses as well as assets and liabilities. During the three and nine months ended January 23, 2026, the Company’s net sales in international markets were approximately 69% and 70%, respectively, of the total Company net sales, as compared to 66% for both the three and nine months ended January 24, 2025. Due to the global nature of our operations, we are exposed to currency exchange rate changes, which may cause fluctuations in earnings and cash flows. For example, a 10% strengthening or weakening of the major non-U.S. currencies against the U.S. dollar in the three and nine months ended January 23, 2026 would have resulted in an increase/decrease to net sales by approximately $55 million and $160 million, respectively, as compared to $45 million and $130 million for the three and nine months ended January 24, 2025, respectively.